VF
VIR icon

Virtu Financial’s Vir Biotechnology VIR Stock Holding History

Virtu Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,241
Closed -$217K – 2288
2026
Q1 		$217K Buy
+24,241
New +$193K 0.01% 988
2025
Q1 		– Sell
-12,836
Closed -$94K – 2077
2024
Q4 		$94K Buy
+12,836
New +$101K 0.01% 1035
2024
Q3 		– Sell
-25,428
Closed -$226K – 1921
2024
Q2 		$226K Buy
+25,428
New +$244K 0.02% 663
2022
Q2 		– Sell
-21,318
Closed -$548K – 2114
2022
Q1 		$548K Buy
21,318
+11,538
+118% +$342K 0.04% 363
2021
Q4 		$409K Buy
9,780
+1,301
+15% +$51K 0.04% 461
2021
Q3 		$369K Buy
+8,479
New +$367K 0.03% 611
2020
Q3 		– Sell
-23,306
Closed -$955K – 1548
2020
Q2 		$955K Buy
+23,306
New +$782K 0.11% 196

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Virtu Financial's VIR Position: Q2 2026 in Review

Virtu Financial sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 24,241 shares — an estimated $217K sold.

Virtu Financial first reported a position in VIR in Q2 2020 and held it in 7 quarters. The position peaked at $955K in Q2 2020. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Virtu Financial reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 24,241 Vir Biotechnology shares in Q2 2026, an estimated $217K.
  • Virtu Financial first reported a position in Vir Biotechnology in Q2 2020 and held it in 7 quarters.
  • Virtu Financial's Vir Biotechnology position peaked at $955K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.